FUNDAMENTALS |
MarketCap: |
0.535 mill
|
EPS: |
-0.0100
|
P/E: |
-0.0500
|
Earnings Date: |
N/A |
SharesOutstanding: |
972.16 mill
|
Avg Daily Volume: |
33.16 mill
|
RATING
2024-05-03 |
C+
|
Sell
|
RATINGS |
Rating CashFlow: |
Sell
|
|
Return On Equity: |
Strong Buy
|
|
Return On Asset: |
Strong Sell
|
|
DE: |
Strong Sell
|
|
P/E: |
Sell
|
|
Price To Book: |
Strong Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.0500 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
0x
|
Company: PE -0.0500 | industry: PE -46.44
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ 0.0006 - 0.0006
( +/- 0.00%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2013-05-03 | Chiang Richard | Sell | 0 | Common Stock |
2013-10-01 | Ferris Holding Inc. | Buy | 41 667 | Common Stock |
2013-10-01 | Epling Barry | Buy | 41 667 | Common Stock |
2013-06-21 | Ferris Holding Inc. | Sell | 0 | Common stock |
2013-06-21 | Epling Barry | Buy | 0 | Common stock |
INSIDER POWER |
0.00
|
Last
6 transactions |
Buy:
83 334 | Sell:
10 000 000 |
Forecast:
16:00 - $0.0006
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.0006
Forecast 2: 16:00 - $0.0006
Forecast 3: 16:00 - $0.0006
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.0006 (10.00% )
|
Volume |
1.201 mill
|
Avg. Vol. |
33.16 mill
|
% of Avg. Vol |
3.62 %
|
Signal 1: |
|
Signal 2: |
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BDPT
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.